Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-046914
Filing Date
2019-08-20
Accepted
2019-08-20 20:35:20
Documents
2
Period of Report
2019-08-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5622
2 POA DOCUMENT poa.txt EX-24.3_869730 3599
  Complete submission text file 0001209191-19-046914.txt   10690
Mailing Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104
Business Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104 734-845-9000
Millendo Therapeutics, Inc. (Issuer) CIK: 0001544227 (see all company filings)

EIN.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MILLENDO THERAPEUTICS, INC. 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104
Business Address
Zeidan Ryan (Reporting) CIK: 0001785724 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35890 | Film No.: 191041115